Media center
Helsinn to present a scientific poster on acute care use following CINV prophylaxis with agents in breast cancer patients at the San Antonio Breast Cancer Symposium (SABCS) 2019
3° trimestre 2019: industria farmaceutica ed energia guidano la crescita del PIL
Helsinn Advanced Synthesis, Biasca: Reduces CO2 emissions by 80% and unveils the new anticancer plant
Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai
Helsinn attends 4th Annual Sino-Swiss Business Awards
Helsinn to co-host alongside Recordati Rare Diseases satellite symposium on MF-CTCL diagnosis optimization at European Academy of Dermatology and Venereology Congress 2019
Comunicato stampa “Farma Industria Ticino and Credit Suisse Award for best student”, mercoledì 18 settembre 2019
Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma (MF-CTCL) treatment at the 49th European Society for Dermatological Research Annual Meeting 2019
Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology
Progetto Talenti
Linkedin